Literature DB >> 29404367

Paradoxical emboli following a pulmonary embolus in the presence of a patent foramen ovale.

Khalid Najib1, Mark Heckle1, Sameh Goubran1, Rhadika Mehta1, Rohan Goswami1, Rami N Khouzam1.   

Abstract

A paradoxical embolism is defined as a systemic arterial embolus due to passage of a venous thrombus through a right to left shunt. We describe a case of acute cerebral vascular accident (CVA), right subclavian arterial embolus, and pulmonary emboli in the setting of a large patent foramen ovale (PFO). A 74-year-old woman with multiple comorbidities presented to the emergency department with acute onset of shortness of breath, weakness, and right arm pain. She was found to have bilateral pulmonary emboli, left CVA, and a right subclavian arterial embolus on computed tomography (CT). She emergently underwent embolectomy of her right upper extremity along with a fasciotomy. On chest CT, a PFO was visualized. Transesophageal echocardiogram (TEE) revealed a large PFO with at least a 3-mm primum/secundum separation and evidence of right to left shunting. Multidisciplinary consensus was that she would benefit from closure of her PFO in order to reduce her risk of further emboli. The patient was agreeable and taken to the catheterization lab where a sizing balloon over a stiff wire was advanced to measure the size of the defect. A 25-mm Cardioform device was successfully delivered across the defect. The patient was started on oral anticoagulation and antiplatelets. In summary, increase in right-sided pressures from pulmonary emboli can cause right to left shunting and lead to a paradoxical embolus. Assessment of patients who present with acute CVA or arterial embolus in the setting of pulmonary emboli with elevated right atrial pressures should include an evaluation for a PFO. Closure of PFO in these patients is of potential additive benefit.

Entities:  

Keywords:  Paradoxical emboli; patent foramen ovale (PFO); pulmonary embolus

Year:  2018        PMID: 29404367      PMCID: PMC5787730          DOI: 10.21037/atm.2018.01.04

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  7 in total

1.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

2.  Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.

Authors:  Shunichi Homma; Ralph L Sacco; Marco R Di Tullio; Robert R Sciacca; J P Mohr
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

3.  Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community.

Authors:  I Meissner; J P Whisnant; B K Khandheria; P C Spittell; W M O'Fallon; R D Pascoe; M Enriquez-Sarano; J B Seward; J L Covalt; J D Sicks; D O Wiebers
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

Review 4.  Patent foramen ovale and paradoxical systemic embolism: a bibliographic review.

Authors:  Philip P Foster; Aladin M Boriek; Bruce D Butler; Michael L Gernhardt; Alfred A Bové
Journal:  Aviat Space Environ Med       Date:  2003-06

5.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

Authors:  Lars Søndergaard; Scott E Kasner; John F Rhodes; Grethe Andersen; Helle K Iversen; Jens E Nielsen-Kudsk; Magnus Settergren; Christina Sjöstrand; Risto O Roine; David Hildick-Smith; J David Spence; Lars Thomassen
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

6.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

Authors:  Jean-Louis Mas; Geneviève Derumeaux; Benoît Guillon; Evelyne Massardier; Hassan Hosseini; Laura Mechtouff; Caroline Arquizan; Yannick Béjot; Fabrice Vuillier; Olivier Detante; Céline Guidoux; Sandrine Canaple; Claudia Vaduva; Nelly Dequatre-Ponchelle; Igor Sibon; Pierre Garnier; Anna Ferrier; Serge Timsit; Emmanuelle Robinet-Borgomano; Denis Sablot; Jean-Christophe Lacour; Mathieu Zuber; Pascal Favrole; Jean-François Pinel; Marion Apoil; Peggy Reiner; Catherine Lefebvre; Patrice Guérin; Christophe Piot; Roland Rossi; Jean-Luc Dubois-Randé; Jean-Christophe Eicher; Nicolas Meneveau; Jean-René Lusson; Bernard Bertrand; Jean-Marc Schleich; François Godart; Jean-Benoit Thambo; Laurent Leborgne; Patrik Michel; Luc Pierard; Guillaume Turc; Martine Barthelet; Anaïs Charles-Nelson; Christian Weimar; Thierry Moulin; Jean-Michel Juliard; Gilles Chatellier
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

7.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

  7 in total
  1 in total

1.  Risk of Stroke in Patients With Patent Foramen Ovale Who Had Pulmonary Embolism.

Authors:  Satyajeet Roy; Han Le; Ayobamidele Balogun; Elizabeth Caskey; Thomas Tessitore; Rasagnya Kota; Janice Hejirika; Siyuan Yu; Long Nguyen; Andrew Louis Lazo; Christopher Yard; Michael Monaghan; Menaka Dhingra; Sneha Modi; Krystal Hunter
Journal:  J Clin Med Res       Date:  2020-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.